Paul Sérusier

“Deeply listening to music opens up new avenues of research I’d never even dreamed of. I feel from now on music should be an essential part of every analysis.”
— Carl Jung ((1875-1961)

"Even though I'm often in a mess, inside me there's still a calm, clear, harmony of music." Vincent van Gogh

“Now we must learn to judge a society more by its sounds, by its art...than by its statistics. “
— Jacques Attali, (1943- )

EUMuse music therapy

LISTENING to MUSIC as a form of medically effective intervention to supplement health system support for ALZHEIMER’S PATIENTS

  • Music therapy is widely considered to be one of the most beneficial methods for enhancing the communication ability of the people with dementia and exerts therapeutic effects through group or individual sessions

  • EuMuse is comprehensive and scientifically based system of designed music listening programs that incorporates multidisciplinary approaches and integration of different academic disciplines

  • Music medicine stands for a scientific evaluation of musical stimuli within a medical frame of reference – including their therapeutic usage and their implementation as a complement to traditional methods of healing

  • EuMuse goal oriented music listening program recommendations stem from a rigorous understanding of the musical material, spectrum of research designs, published scientific research and the latent needs and motivations of the clients

  • Music material is considered not as a static content to be mastered, but as personal, current and evolving

  • EuMuse Protocol includes assessment, goal development, music intervention design, ongoing evaluation

  • Advantages - Relative low cost, ease of administration, no side effects i.e. little capacity to do harm By its vision and action, EuMuse  music treatment program is a perfect complementary solution to the local, national and global action plans towards treatments, care and support of people facing Alzheimer’s disease  conditions

Primary Beneficiaries:           Alzheimer’s patients

Secondary Beneficiaries:       Family nucleus, communities, society

Future Beneficiaries: Health centers, Continuing Care Retirement Communities (CCRCs), and enterprises interested to promote the effective and replicable methods in health promotion, rehabilitation, disease management and preventive medicine for their citizens

* Worldwide dementia cases are to triple by 2050 & are projected to be the costliest health condition. Alzheimer’s disease and other forms of dementia ranked as the 7th leading cause of death. Of the total U.S. population – about 1 in 9 people (11%) age 65 and older has Alzheimer’s dementia. In 2021, AD was the 5th-leading cause of death